AEE vs CNP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Ameren Corporation (AEE) shows a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score, limiting distress risk assessment. Despite solid profitability metrics and strong recent earnings growth, the company faces concerns around liquidity, high leverage, and bearish insider activity. Valuation is near peer average, supported by analyst buy consensus and a reasonable dividend, but technical trend and insider selling suggest caution. The stock trades above the Graham Number of $74.13 but below the growth-based intrinsic value of $152.51, reflecting moderate premium expectations.
CNP presents a conflict between strong historical performance and current overvaluation. The deterministic baseline is weak, with a Piotroski F-Score of 4/9 (Stable) and a current price of $42.47 that significantly exceeds both the Graham Number ($25.03) and Intrinsic Value ($27.79). While the company maintains healthy operating margins and a sustainable dividend payout, the high Debt/Equity ratio (2.16) and bearish technical trend (10/100) suggest limited immediate upside. The stock is currently trading at a premium that is not fully supported by its low revenue growth (1.90%).
Compare Another Pair
Related Comparisons
AEE vs CNP: Head-to-Head Comparison
This page compares Ameren Corporation (AEE) and CenterPoint Energy, Inc. (CNP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.